Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Raquel Sánchez Valle, coordinator of the Behavior and Dementia Group of the Spanish Society ... Given the complexity of ...

Dementia is a condition that affects memory, thinking, and the ability to perform everyday tasks. As it progresses, it can ...

The global neuromodulation device market will be worth $11.4bn by 2033, as per a market model from GlobalData.

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...

Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer's ...

As people age, the body changes as part of the normal ageing process, such as greying hair and loss of elasticity in the skin ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Ann Lange was diagnosed with Alzheimer's in 2015, but with the help of clinical trials her disease has not progressed past ...

A compassionate, multidisciplinary approach can help manage one of the most complex challenges nursing homes and other long-term care providers face.